Transcriptomic analysis reveals distinct molecular signatures and regulatory networks of osteoarthritic chondrocytes versus mesenchymal stem cells during chondrogenesis
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
40242907
DOI
10.5507/bp.2025.008
Knihovny.cz E-zdroje
- Klíčová slova
- chondrocytes, differentially expressed genes (DEGs), gene ontology (GO), hub genes, mesenchymal stem cells, osteoarthritis, protein-protein interaction (PPI),
- MeSH
- artróza kolenních kloubů * genetika MeSH
- buněčná diferenciace genetika MeSH
- chondrocyty * metabolismus fyziologie MeSH
- chondrogeneze * genetika MeSH
- genové regulační sítě * MeSH
- lidé MeSH
- mapy interakcí proteinů MeSH
- mezenchymální kmenové buňky * metabolismus fyziologie MeSH
- stanovení celkové genové exprese MeSH
- transkriptom * MeSH
- výpočetní biologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Recent regenerative studies imply conflicting results on knee osteoarthritic (OA) chondrocytes and mesenchymal stem cells (MSC)-mediated cartilage constructs in terms of compressive properties and tensile strength. This could be attributed to different gene expression patterns between MSC and OA chondrocytes during chondrogenic differentiation. Therefore, we analyzed differentially expressed genes (DEGs) between OA and MSC-derived chondrocytes using bioinformatics tools. METHODS: We downloaded and analyzed the GSE19664 dataset from the Gene Expression Omnibus to identify DEGs. DAVID was used to perform Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses, while a protein-protein interaction network of DEGs was constructed through the Search Tool for the Retrieval of Interacting Genes (STRING) and identified hub genes by CytoHubba. RESULTS: A total of 43 DEGs identified (15 downregulated and 28 upregulated) were found to be deregulated between OA and MSC-derived chondrocytes. KEGG analysis revealed the enrichment of complement and coagulation cascades and other pathways among the studied chondrocytes. The pathway enrichment identified top KEGG, gene ontology biological process, molecular function, and cellular component. The hub networks identified the top 5 hub genes involved in chondrogenesis, including CLU, PLAT, CP, TIMP3, and SERPINA1. CONCLUSIONS: Our results identified significant genes involved in chondrogenesis. These findings provide new avenues for exploring the genetic mechanism underlying cartilage synthesis and novel targets for preclinical intervention and clinical treatment.
BioSource Tech Ambala 133101 Haryana India
Center of Excellence Akhand Jyoti Eye Hospital Mastichak Patna Bihar 841219 India
Department of Information Technology Office Taipei Medical University Hospital Taipei 11031 Taiwan
Department of Medicine Research Taipei Medical University Hospital Taipei 11031 Taiwan
Department of Orthopedic Surgery Mackay Memorial Hospital Taipei City 104 Taiwan
Executive Programme in Healthcare Management Indian Institute of Management Lucknow 226013 India
Mackay Junior College of Medicine Nursing and Management New Taipei City 252 Taiwan
Zobrazit více v PubMed
Zhang W, Ouyang H, Dass CR, Xu J. Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res 2016;4:15040. doi: 10.1038/boneres.2015.40 PubMed DOI
Li MH, Xiao R, Li JB, Zhu Q. Regenerative approaches for cartilage repair in the treatment of osteoarthritis. Osteoarthritis Cartilage 2017;25(10):1577-87. doi: 10.1016/j.joca.2017.07.004 PubMed DOI
Pap T, Korb-Pap A. Cartilage damage in osteoarthritis and rheumatoid arthritis-two unequal siblings. Nat Rev Rheumatol 2015;11(10):606-15. doi: 10.1038/nrrheum.2015.95 PubMed DOI
Felson DT. Clinical practice. Osteoarthritis of the knee. N Engl J Med 2006;354(8):841-8. doi: 10.1056/NEJMcp051726. Erratum in: N Engl J Med 2006;354(23):2520. PubMed DOI
Szponder T, Latalski M, Danielewicz A, Krać K, Kozera A, Drzewiecka B, Nguyen Ngoc D, Dobko D, Wessely-Szponder J. Osteoarthritis: Pathogenesis, Animal Models, and New Regenerative Therapies. J Clin Med 2022;12(1):5. doi: 10.3390/jcm12010005 PubMed DOI
m GI. Current status of regenerative medicine in osteoarthritis. Bone Joint Res 2021;10(2):134-6. doi: 10.1302/2046-3758.102.BJR-2020-0517.R1 PubMed DOI
Ip HL, Nath DK, Sawleh SH, Kabir MH, Jahan N. Regenerative Medicine for Knee Osteoarthritis - The Efficacy and Safety of Intra-Articular Platelet-Rich Plasma and Mesenchymal Stem Cells Injections: A Literature Review. Cureus 2020;12:e10575. 2020/10/27. doi: 10.7759/cureus.10575 PubMed DOI
Lu L, Dai C, Zhang Z, Du H, Li S, Ye P, Fu Q, Zhang L, Wu X, Dong Y, Song Y, Zhao D, Pang Y, Bao C. Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial. Stem Cell Res Ther 2019;10(1):143. doi: 10.1186/s13287-019-1248-3 PubMed DOI
Bernstein P, Sticht C, Jacobi A, Liebers C, Manthey S, Stiehler M. Expression pattern differences between osteoarthritic chondrocytes and mesenchymal stem cells during chondrogenic differentiation. Osteoarthritis Cartilage 2010;18(12):1596-607. doi: 10.1016/j.joca.2010.09.007 PubMed DOI
Nesic D, Whiteside R, Brittberg M, Wendt D, Martin I, Mainil-Varlet P. Cartilage tissue engineering for degenerative joint disease. Adv Drug Deliv Rev 2006;58(2):300-22. doi: 10.1016/j.addr.2006.01.012 PubMed DOI
Wei P, Bao R. Intra-Articular Mesenchymal Stem Cell Injection for Knee Osteoarthritis: Mechanisms and Clinical Evidence. Int J Mol Sci 2022;24(1):59. doi: 10.3390/ijms24010059 PubMed DOI
Zeng N, Yan ZP, Chen XY, Ni GX. Infrapatellar Fat Pad and Knee Osteoarthritis. Aging Dis 2020;11(5):1317-28. doi: 10.14336/AD.2019.1116 PubMed DOI
Agar G, Blumenstein S, Bar-Ziv Y, Kardosh R, Schrift-Tzadok M, Gal-Levy R, Fischler T, Goldschmid R, Yayon A. The Chondrogenic Potential of Mesenchymal Cells and Chondrocytes from Osteoarthritic Subjects: A Comparative Analysis. Cartilage 2011;2(1):40-9. doi: 10.1177/1947603510380899 PubMed DOI
Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007;213(2):341-7. doi: 10.1002/jcp.21200 PubMed DOI
Karlsson C, Brantsing C, Svensson T, Brisby H, Asp J, Tallheden T, Lindahl A. Differentiation of human mesenchymal stem cells and articular chondrocytes: analysis of chondrogenic potential and expression pattern of differentiation-related transcription factors. J Orthop Res 2007;25(2):152-63. doi: 10.1002/jor.20287 PubMed DOI
Mauck R, Yuan X, Tuan RS. Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. Osteoarthritis Cartilage 2006;14:179-89. DOI
Erickson IE, Huang AH, Chung C, Li RT, Burdick JA, Mauck RL. Differential maturation and structure-function relationships in mesenchymal stem cell- and chondrocyte-seeded hydrogels. Tissue Eng Part A 2009;15(5):1041-52. doi: 10.1089/ten.tea.2008.0099 PubMed DOI
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4(5):P3. DOI
Huang B, Li P, Chen M, Peng L, Luo X, Tian G, Wang H, Wu L, Tian Q, Li H, Yang Y, Jiang S, Yang Z, Zha K, Sui X, Liu S, Guo Q. Hydrogel composite scaffolds achieve recruitment and chondrogenesis in cartilage tissue engineering applications. J Nanobiotechnology 2022;20(1):25. doi: 10.1186/s12951-021-01230-7 PubMed DOI
Wan J, Zhang G, Li X, Qiu X, Ouyang J, Dai J, Min S. Matrix Metalloproteinase 3: A Promoting and Destabilizing Factor in the Pathogenesis of Disease and Cell Differentiation. Front Physiol 2021;12:663978. doi: 10.3389/fphys.2021.663978 PubMed DOI
Fernandes AM, Herlofsen SR, Karlsen TA, Küchler AM, Fløisand Y, Brinchmann JE. Similar properties of chondrocytes from osteoarthritis joints and mesenchymal stem cells from healthy donors for tissue engineering of articular cartilage. PLoS One 2013;8(5):e62994. doi: 10.1371/journal.pone.0062994 PubMed DOI
Huh YH, Ryu JH, Shin S, Lee DU, Yang S, Oh KS, Chun CH, Choi JK, Song WK, Chun JS. Esophageal cancer related gene 4 (ECRG4) is a marker of articular chondrocyte differentiation and cartilage destruction. Gene 2009;448(1):7-15. doi: 10.1016/j.gene.2009.08.015 PubMed DOI
Li C, Zheng Z. Identification of Novel Targets of Knee Osteoarthritis Shared by Cartilage and Synovial Tissue. Int J Mol Sci 2020;21(17):6033. doi: 10.3390/ijms21176033 PubMed DOI
Recklies A, Bernier S, Camper L. P142 Toll-like receptor activtion regulates expression of the chitinase-like proteins in articular chondrocytes. Osteoarthritis and Cartilage 2006;14(Suppl B): S87. doi: 10.1016/S1063-4584(07)60594-9 DOI
Jankowski M, Kaczmarek M, Wąsiatycz G, Konwerska A, Dompe C, Bukowska D, Antosik P, Mozdziak P, Kempisty B. Expression Profile of New Gene Markers Involved in Differentiation of Canine Adipose-Derived Stem Cells into Chondrocytes. Genes (Basel) 2022;13(9):1664. doi: 10.3390/genes13091664 PubMed DOI
ecklies AD, Ling H, White C, Bernier SM. Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes. J Biol Chem 2005;280(50):41213-21. doi: 10.1074/jbc.M510146200 PubMed DOI
Di Rosa M, Szychlinska MA, Tibullo D, Malaguarnera L, Musumeci G. Expression of CHI3L1 and CHIT1 in osteoarthritic rat cartilage model. A morphological study. Eur J Histochem 2014;58(3):2423. doi: 10.4081/ejh.2014.2423 PubMed DOI
Zhou Z, Yao B, Zhao D. Runx3 regulates chondrocyte phenotype by controlling multiple genes involved in chondrocyte proliferation and differentiation. Mol Biol Rep 2020;47(8):5773-92. doi: 10.1007/s11033-020-05646-6 PubMed DOI
White MJ, Roife D, Gomer RH. Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation. J Immunol 2015;195:1858-67. doi: 10.4049/jimmunol.1500365 PubMed DOI
Ohshima S, Kuchen S, Seemayer CA, Kyburz D, Hirt A, Klinzing S, Michel BA, Gay RE, Liu FT, Gay S, Neidhart M. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum 2003;48(10):2788-95. doi: 10.1002/art.11287 PubMed DOI
DeRoo EP, Wrobleski SK, Shea EM, Al-Khalil RK, Hawley AE, Henke PK, Myers DD Jr, Wakefield TW, Diaz JA. The role of galectin-3 and galectin-3-binding protein in venous thrombosis. Blood 2015;125(11):1813-21. doi: 10.1182/blood-2014-04-569939 PubMed DOI
Udomsinprasert W, Ungsudechachai T, Wunthong S, Yuttanarad S, Jittikoon J, Honsawek S. Effect of galectin-3 on synovial inflammation in knee osteoarthritis via stimulating phosphatidylinositol-3-kinase/Akt pathway. Int Immunopharmacol 2023;122:110673. doi: 10.1016/j.intimp.2023.110673 PubMed DOI
Wei R, Zhang L, Hu W, Wu J, Zhang W. CSTA plays a role in osteoclast formation and bone resorption by mediating the DAP12/TREM2 pathway. Biochem Biophys Res Commun 2022;627:12-20. doi: 10.1016/j.bbrc.2022.08.033 PubMed DOI
Hopwood B, Tsykin A, Findlay DM, Fazzalari NL. Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling. Arthritis Res Ther 2007;9(5):R100. doi: 10.1186/ar2301 PubMed DOI
Wang M, Liu C, Zhang Y, Hao Y, Zhang X, Zhang YM. Protein interaction and microRNA network analysis in osteoarthritis meniscal cells. Genet Mol Res 2013;12(1):738-46. doi: 10.4238/2013 DOI
Gobezie R, Kho A, Krastins B, Sarracino DA, Thornhill TS, Chase M, Millett PJ, Lee DM. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther 2007;9(2):R36. doi: 10.1186/ar2172 PubMed DOI
Uchimura T, Foote AT, Smith EL, Matzkin EG, Zeng L. Insulin-Like Growth Factor II (IGF-II) Inhibits IL-1β-Induced Cartilage Matrix Loss and Promotes Cartilage Integrity in Experimental Osteoarthritis. J Cell Biochem 2015;116(12):2858-69. doi: 10.1002/jcb.25232 PubMed DOI
Tanaka N, Tsuno H, Ohashi S, Iwasawa M, Furukawa H, Kato T, Fukui N. The attenuation of insulin-like growth factor signaling may be responsible for relative reduction in matrix synthesis in degenerated areas of osteoarthritic cartilage. BMC Musculoskelet Disord 2021;22(1):231. doi: 10.1186/s12891-021-04096-w PubMed DOI
Uchimura T, Hollander JM, Nakamura DS, Liu Z, Rosen CJ, Georgakoudi I, Zeng L. An essential role for IGF2 in cartilage development and glucose metabolism during postnatal long bone growth. Development 2017;144(19):3533-46. doi: 10.1242/dev.155598 PubMed DOI
Singh S, Jindal D, Khanna R. Can serum MMP-3 diagnose early knee osteoarthritis? J Orthopaedics 2023;38:42-6. doi: 10.1016/j.jor.2023.02.014 PubMed DOI
Fandridis E, Apergis G, Korres DS, Nikolopoulos K, Zoubos AB, Papassideri I, Trougakos IP. Increased expression levels of apolipoprotein J/clusterin during primary osteoarthritis. In Vivo 2011;25(5):745-9.
Kalvaityte U, Matta C, Bernotiene E, Pushparaj PN, Kiapour AM, Mobasheri A. Exploring the translational potential of clusterin as a biomarker of early osteoarthritis. J Orthop Translat 2021;32:77-84. doi: 10.1016/j.jot.2021.10.001 PubMed DOI
Ungsudechachai T, Honsawek S, Jittikoon J, Udomsinprasert W. Clusterin Is Associated with Systemic and Synovial Inflammation in Knee Osteoarthritis. Cartilage 2021;13(1_suppl):1557S-1565S. doi: 10.1177/1947603520958149 PubMed DOI
Rodríguez-Rivera C, Garcia MM, Molina-Álvarez M, González-Martín C, Goicoechea C. Clusterin: Always protecting. Synthesis, function and potential issues. Biomed Pharmacother 2021;134:111174. doi: 10.1016/j.biopha.2020.111174 PubMed DOI
Kovács P, Pushparaj PN, Takács R, Mobasheri A, Matta C. The clusterin connectome: Emerging players in chondrocyte biology and putative exploratory biomarkers of osteoarthritis. Front Immunol 2023;14:1103097. doi: 10.3389/fimmu.2023.1103097 PubMed DOI
Tarquini C, Pucci S, Scioli MG, Doldo E, Agostinelli S, D'Amico F, Bielli A, Ferlosio A, Caredda E, Tarantino U, Orlandi A. Clusterin exerts a cytoprotective and antioxidant effect in human osteoarthritic cartilage. Aging (Albany NY) 2020;12(11):10129-46. doi: 10.18632/aging.103310 PubMed DOI
Devauchelle V, Essabbani A, De Pinieux G, Germain S, Tourneur L, Mistou S, Margottin-Goguet F, Anract P, Migaud H, Le Nen D, Lequerré T, Saraux A, Dougados M, Breban M, Fournier C, Chiocchia G. Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis. J Immunol 2006;177(9):6471-9. doi: 10.4049/jimmunol.177.9.6471 PubMed DOI
Kiapour AM, Sieker JT, Proffen BL, Lam TT, Fleming BC, Murray MM. Synovial fluid proteome changes in ACL injury-induced posttraumatic osteoarthritis: Proteomics analysis of porcine knee synovial fluid. PLoS One 2019;14(3):e0212662. doi: 10.1371/journal.pone.0212662 PubMed DOI
Raghu H, Jone A, Cruz C, Rewerts CL, Frederick MD, Thornton S, Degen JL, Flick MJ. Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice. Arthritis Rheumatol 2014;66(6):1504-16. doi: 10.1002/art.38402 PubMed DOI
Moritake A, Kawao N, Okada K, Tatsumi K, Ishida M, Okumoto K, Matsuo O, Akagi M, Kaji H. Plasminogen activator inhibitor-1 deficiency enhances subchondral osteopenia after induction of osteoarthritis in mice. BMC Musculoskelet Disord 2017;18(1):392. doi: 10.1186/s12891-017-1752-5 PubMed DOI
Li J, Ny A, Leonardsson G, Nandakumar KS, Holmdahl R, Ny T. The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis. Am J Pathol 2005;166(3):783-92. doi: 10.1016/S0002-9440(10)62299-7 PubMed DOI
Zhu G, Tang Y, Liang X, Zheng M, Yang J, Zhou H, Li L, Qin T. Role of hypoxia-inducible factor-1 alpha in the regulation of plasminogen activator activity in rat knee joint chondrocytes. Osteoarthritis Cartilage 2009;17(11):1494-502. doi: 10.1016/j.joca.2009.05.005 PubMed DOI
Sulastri D, Arnadi A, Afriwardi A, Desmawati D, Amir A, Irawati N, Yanis A, Yusrawati Y. Risk factor of elevated matrix metalloproteinase-3 gene expression in synovial fluid in knee osteoarthritis women. PLoS One 2023;18(3):e0283831. doi: 10.1371/journal.pone.0283831 PubMed DOI
Wilkinson DJ, Arques MDC, Huesa C, Rowan AD. Serine proteinases in the turnover of the cartilage extracellular matrix in the joint: implications for therapeutics. Br J Pharmacol 2019;176(1):38-51. doi: 10.1111/bph.14173 PubMed DOI
Wilkinson DJ. Serpins in cartilage and osteoarthritis: what do we know? Biochem Soc Trans 202;49(2):1013-26. doi: 10.1042/BST20201231 PubMed DOI
Boeuf S, Steck E, Pelttari K, Hennig T, Buneb A, Benz K, Witte D, Sültmann H, Poustka A, Richter W. Subtractive gene expression profiling of articular cartilage and mesenchymal stem cells: serpins as cartilage-relevant differentiation markers. Osteoarthritis Cartilage 2008;16(1):48-60. doi: 10.1016/j.joca.2007.05.008 PubMed DOI
Wanner J, Subbaiah R, Skomorovska-Prokvolit Y, Shishani Y, Boilard E, Mohan S, Gillespie R, Miyagi M, Gobezie R. Proteomic profiling and functional characterization of early and late shoulder osteoarthritis. Arthritis Res Ther 2013;15(6):R180. doi: 10.1186/ar4369 PubMed DOI
Lin W, Xu L, Li G. Molecular Insights Into Lysyl Oxidases in Cartilage Regeneration and Rejuvenation. Front Bioeng Biotechnol 2020;8:359. doi: 10.3389/fbioe.2020.00359 Erratum in: Front Bioeng Biotechnol 2020;8:598323. doi: 10.3389/fbioe.2020.598323 PubMed DOI
Tong Z, Liu Y, Chen B, Yan L, Hao D. Association between MMP3 and TIMP3 polymorphisms and risk of osteoarthritis. Oncotarget 2017;8(48):83563-9. doi: 10.18632/oncotarget.18745 PubMed DOI
Troeberg L. Engineering TIMP-3 for OA therapy. Osteoarthritis Cartilage 2017;25:S2. doi: 10.1016/j.joca.2017.02.007 DOI
Suzuki H, Nezaki Y, Kuno E, Sugiyama I, Mizutani A, Tsukagoshi N. Functional roles of the tissue inhibitor of metalloproteinase 3 (TIMP-3) during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells. Biosci Biotechnol Biochem 2003;67(8):1737-43. doi: 10.1271/bbb.67.1737 PubMed DOI
Morris KJ, Cs-Szabo G, Cole AA. Characterization of TIMP-3 in human articular talar cartilage. Connect Tissue Res 2010;51(6):478-90. doi: 10.3109/03008201003686958 PubMed DOI
Chaudhari NY, Sontakke A. Markers of inflammation in rheumatoid arthritis and Osteoarthritis. Int J Med Health Sci 2020; 9(2):25-8.
Scotece M, Koskinen-Kolasa A, Pemmari A, Leppänen T, Hämäläinen M, Moilanen T, Moilanen E, Vuolteenaho K. Novel adipokine associated with OA: retinol binding protein 4 (RBP4) is produced by cartilage and is correlated with MMPs in osteoarthritis patients. Inflamm Res 2020;69(4):415-21. doi: 10.1007/s00011-020-01326-0 PubMed DOI
Pazos-Pérez A, Piñeiro-Ramil M, Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, Crespo-Golmar A, López-Fagúndez M, Aranda JC, Bravo SB, Jorge-Mora A, Gómez R. The Hepatokine RBP4 Links Metabolic Diseases to Articular Inflammation. Antioxidants (Basel) 2024;13(1):124. doi: 10.3390/antiox13010124 PubMed DOI
Shepherd C, Zhu D, Skelton AJ, Combe J, Threadgold H, Zhu L, Vincent TL, Stuart P, Reynard LN, Loughlin J. Functional Characterization of the Osteoarthritis Genetic Risk Residing at ALDH1A2 Identifies rs12915901 as a Key Target Variant. Arthritis Rheumatol 2018;70(10):1577-87. doi: 10.1002/art.40545 PubMed DOI
im SK, Kwak SG, Choe JY. Decline of Lung Function in Knee and Spine Osteoarthritis in the Korean Population: Cross-Sectional Analysis of Data from the Korea National Health and Nutrition Examination Survey. Healthcare (Basel) 2022;10(4):736. doi: 10.3390/healthcare10040736 PubMed DOI
Koo HK, Song P, Lee JH. Novel association between asthma and osteoarthritis: a nationwide health and nutrition examination survey. BMC Pulm Med 2021;21(1):59. doi: 10.1186/s12890-021-01425-6 PubMed DOI
Wshah A, Guilcher SJ, Goldstein R, Brooks D. Prevalence of osteoarthritis in individuals with COPD: a systematic review. Int J Chron Obstruct Pulmon Dis 2018;13:1207-16. doi: 10.2147/COPD.S158614 PubMed DOI
Park HJ, Leem AY, Lee SH, Song JH, Park MS, Kim YS, Kim SK, Chang J, Chung KS. Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey. Int J Chron Obstruct Pulmon Dis 2015;10:1571-82. doi: 10.2147/COPD.S85767 PubMed DOI
Wang Q, Rozelle AL, Lepus CM, Scanzello CR, Song JJ, Larsen DM, Crish JF, Bebek G, Ritter SY, Lindstrom TM, Hwang I, Wong HH, Punzi L, Encarnacion A, Shamloo M, Goodman SB, Wyss-Coray T, Goldring SR, Banda NK, Thurman JM, Gobezie R, Crow MK, Holers VM, Lee DM, Robinson WH. Identification of a central role for complement in osteoarthritis. Nat Med 2011;17(12):1674-9. doi: 10.1038/nm.2543 PubMed DOI
Silawal S, Triebel J, Bertsch T, Schulze-Tanzil G. Osteoarthritis and the Complement Cascade. Clin Med Insights Arthritis Musculoskelet Disord 2018;11:1179544117751430. doi: 10.1177/1179544117751430 PubMed DOI
Struglics A, Okroj M, Swärd P, Frobell R, Saxne T, Lohmander LS, Blom AM. The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis. Arthritis Res Ther 2016;18(1):223. doi: 10.1186/s13075-016-1123-x PubMed DOI
Rosas S, Kwok A, Moore J, Shi L, Smith TL, Tallant EA, Kerr BA, Willey JS. Osteoarthritis as a Systemic Disease Promoted Prostate Cancer In Vivo and In Vitro. Int J Mol Sci 2024;25(11):6014. doi: 10.3390/ijms25116014 PubMed DOI
Turkiewicz A, Díaz Y, Poveda-Marina JL, Duarte-Salles T, Prieto-Alhambra. Knee osteoarthritis and risk of ten cancers in a large real-world matched cohort study. Osteoarthritis Cartilage 2020;28:S421-S422. doi: 10.1016/j.joca.2020.02.654 DOI